• Ameliorating diabetes and orphan diseases by bridging science and clinical medicine
  • Discovering Innovations, Implementing Solutions in Medical Science and Clinical Practice
  • Strong team, broad network, commitment to unmeet medical needs lead to sustainable development


SatRx is a small Russian company - developer of the medicines created in 2010 on the basis of ChemRar High Tech Center to create novel products and their synergistic combinations to treat diabetes, obesity and other metabolic diseases.